In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA<sub>1c</sub> at 52 wk.
Where this comes from
- Record sourced from PubMed, PMID 41052450.
- Also identified by DOI 10.7326/ANNALS-25-03845-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text].